LRMR logo

Larimar Therapeutics (LRMR) Company Overview

Profile

Full Name:

Larimar Therapeutics, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

June 19, 2014

Indexes:

Not included

Description:

Larimar Therapeutics focuses on developing innovative treatments for rare diseases, particularly those affecting the central nervous system. The company aims to improve patient outcomes through advanced therapies, with a strong emphasis on research and clinical trials to bring new solutions to market.

Events Calendar

Earnings

Next earnings date:

Mar 14, 2025

Recent quarterly earnings:

Oct 30, 2024

Recent annual earnings:

Mar 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

May 29, 2020

Analyst ratings

Recent major analysts updates

Jan 29, 25 Truist Securities
Buy
Jan 24, 25 HC Wainwright & Co.
Buy
Dec 17, 24 HC Wainwright & Co.
Buy
Dec 16, 24 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 16, 24 Oppenheimer
Outperform
Oct 3, 24 Wedbush
Outperform
Oct 2, 24 HC Wainwright & Co.
Buy
Sep 12, 24 Jones Trading
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Larimar Therapeutics?
  • Does Larimar Therapeutics pay dividends?
  • What sector is Larimar Therapeutics in?
  • What industry is Larimar Therapeutics in?
  • What country is Larimar Therapeutics based in?
  • When did Larimar Therapeutics go public?
  • Is Larimar Therapeutics in the S&P 500?
  • Is Larimar Therapeutics in the NASDAQ 100?
  • Is Larimar Therapeutics in the Dow Jones?
  • When was Larimar Therapeutics's last earnings report?
  • When does Larimar Therapeutics report earnings?
  • Should I buy Larimar Therapeutics stock now?

What is the ticker symbol for Larimar Therapeutics?

The ticker symbol for Larimar Therapeutics is NASDAQ:LRMR

Does Larimar Therapeutics pay dividends?

No, Larimar Therapeutics does not pay dividends

What sector is Larimar Therapeutics in?

Larimar Therapeutics is in the Healthcare sector

What industry is Larimar Therapeutics in?

Larimar Therapeutics is in the Biotechnology industry

What country is Larimar Therapeutics based in?

Larimar Therapeutics is headquartered in United States

When did Larimar Therapeutics go public?

Larimar Therapeutics's initial public offering (IPO) was on June 19, 2014

Is Larimar Therapeutics in the S&P 500?

No, Larimar Therapeutics is not included in the S&P 500 index

Is Larimar Therapeutics in the NASDAQ 100?

No, Larimar Therapeutics is not included in the NASDAQ 100 index

Is Larimar Therapeutics in the Dow Jones?

No, Larimar Therapeutics is not included in the Dow Jones index

When was Larimar Therapeutics's last earnings report?

Larimar Therapeutics's most recent earnings report was on Oct 30, 2024

When does Larimar Therapeutics report earnings?

The next expected earnings date for Larimar Therapeutics is Mar 14, 2025

Should I buy Larimar Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions